AR244550A1 - Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa - Google Patents

Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa

Info

Publication number
AR244550A1
AR244550A1 AR79277427A AR27742779A AR244550A1 AR 244550 A1 AR244550 A1 AR 244550A1 AR 79277427 A AR79277427 A AR 79277427A AR 27742779 A AR27742779 A AR 27742779A AR 244550 A1 AR244550 A1 AR 244550A1
Authority
AR
Argentina
Prior art keywords
thienamycin
type compound
antibacterial composition
dipeptidase inhibitor
dipeptidase
Prior art date
Application number
AR79277427A
Other languages
English (en)
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26728043&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR244550(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of AR244550A1 publication Critical patent/AR244550A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AR79277427A 1978-07-24 1979-07-04 Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa AR244550A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92721378A 1978-07-24 1978-07-24
US5023279A 1979-06-22 1979-06-22

Publications (1)

Publication Number Publication Date
AR244550A1 true AR244550A1 (es) 1993-11-30

Family

ID=26728043

Family Applications (1)

Application Number Title Priority Date Filing Date
AR79277427A AR244550A1 (es) 1978-07-24 1979-07-04 Procedimiento para obtener una composicion de antibioticos del tipo de la tienamicina con inhibidores de la dipeptidasa

Country Status (19)

Country Link
EP (1) EP0007614B1 (es)
AR (1) AR244550A1 (es)
AU (1) AU529315B2 (es)
CA (1) CA1136549A (es)
CZ (1) CZ280583B6 (es)
DD (1) DD145059A5 (es)
DE (1) DE2964609D1 (es)
EG (1) EG14367A (es)
ES (1) ES482774A1 (es)
FI (1) FI792282A (es)
GR (1) GR69997B (es)
HK (1) HK23286A (es)
HU (1) HU182973B (es)
IE (1) IE51691B1 (es)
IL (1) IL57798A (es)
NZ (1) NZ190993A (es)
PH (1) PH16620A (es)
PT (1) PT69955B (es)
SK (1) SK513779A3 (es)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071843A (en) * 1978-07-24 1991-12-10 Merck & Co., Inc. Combination of 2-substituted carbapenems with dipeptidase inhibitors
US4880793A (en) * 1978-07-24 1989-11-14 Merck & Co., Inc. Combination of thienamycin-type antibiotics with dipeptidase inhibitors
IE50333B1 (en) * 1979-11-02 1986-04-02 Merck & Co Inc Antibacterial compositions comprising a beta-lactam-type compound and a 3-substituted propenoate
PT73640B (en) * 1980-09-17 1983-10-19 Merck & Co Inc Process for preparing chemical compounds selectively inhibit the metabolism of dipeptidase
EP0048025B1 (en) * 1980-09-17 1986-01-15 Merck & Co. Inc. Antibacterial composition of thienamycin type compound and a dipeptidase inhibitor
DE48301T1 (de) * 1980-09-24 1983-01-20 Merck & Co., Inc., 07065 Rahway, N.J. 2-(cyclopropancarboxamido)-2-alkensaeuren, deren ester und salze und daraus bestehende bakterienhemmende zusammensetzungen mit einer verbindung des typs thienamycin.
NZ201471A (en) * 1981-08-10 1985-09-13 Merck & Co Inc Antibacterial compositions containing penems and dipeptidase inhibitors
JPS6025952A (ja) * 1983-07-20 1985-02-08 Sumitomo Chem Co Ltd 光学活性2,2−ジメチルシクロプロパン−1−カルボン酸誘導体の製造法
EP0161546B1 (en) * 1984-04-30 1989-12-13 Merck & Co. Inc. Combination of 2-substituted carbapenems with dipeptidase inhibitors
CA1273011A (en) * 1984-07-02 1990-08-21 Susan M. Schmitt Carbapenems having an externally alkylated mono- or bicyclic 2-quaternary heteroarylalkylthio substituent
CA1273012A (en) * 1984-07-02 1990-08-21 Burton G. Christensen 1-methylcarbapenems having an externally alkylated mono- of bicyclic 2-quarternary heteroarylalkylthio substituent
IE851586L (en) * 1984-07-02 1986-01-02 Interchem Internat S A I methylcarbapenems having a 2-quaternary¹heteroarylalkylthio substituent
IE59395B1 (en) * 1984-10-15 1994-02-23 Sankyo Co Composition containing a penem or carbapenem antibiotic
US4680292A (en) * 1984-12-13 1987-07-14 Merck & Co., Inc. Carbapenems and 1-methylcarbapenems having a 2-heteroaryliumaliphatic substituent
US4739113A (en) * 1986-05-30 1988-04-19 Merck & Co., Inc. Bis(cyclopropanecarboxamido)alkadienedioic acids as renal dipeptidase inhibitors
EP0464900A3 (en) 1990-06-26 1992-07-22 Merck & Co. Inc. 2-biphenyl-carbapenems
CA2052730A1 (en) 1990-10-11 1992-04-12 Frank P. Dininno 2-(substituted-dibenzofuranyl and dibenzothienyl) carbapenem antibacterial agents
EP0497353B1 (en) * 1991-02-01 2002-05-08 Suntory Limited Use of cilastatin, glutathione or N-acetyl-L-cysteine for the preparation of a medicament for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics
US6297231B1 (en) 1996-10-28 2001-10-02 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6255300B1 (en) 1997-09-09 2001-07-03 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6277843B1 (en) 1997-09-17 2001-08-21 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6271222B1 (en) 1998-05-28 2001-08-07 Merck & Co., Inc. Penem antibacterial compounds, compositions and methods of treatment
US6284753B2 (en) 1998-06-02 2001-09-04 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
US6310055B2 (en) 1998-06-02 2001-10-30 Merck & Co., Inc. Halophenoxy substituted carbapenem antibacterial compounds
US6288054B1 (en) 1998-06-02 2001-09-11 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment
CA2335510A1 (en) 1998-06-25 1999-12-29 Merck & Co., Inc. Naphtho[1,8-de]thiasin-2-yl methyl carbapenem antibacterials
US6294528B1 (en) 1998-06-25 2001-09-25 Merck & Co., Inc. Carbapenem antibacterial compounds, compositions containing such compounds and method of treatment
EP1089729A4 (en) 1998-06-25 2002-11-06 Merck & Co Inc ANTIBACTERIAL CARBAPENEM COMPOUNDS, COMPILATIONS THAT CONTAIN THEM AND TREATMENT METHODS
EP1090001A4 (en) 1998-06-25 2002-11-27 Merck & Co Inc HETEROCYCLOMETHYL SUBSTITUTED ANTIBACTERIAL CARBAPENEM COMPOUNDS
CA2335571A1 (en) 1998-06-25 1999-12-29 Merck & Co. Inc. (heterocyclic) methyl substituted carbapenem antibacterials
US6316488B1 (en) 1999-06-17 2001-11-13 Merck & Co., Inc. Antibiotic compound
US6221859B1 (en) 1999-08-27 2001-04-24 Merck & Co., Inc. Carbapenem antibacterial compositions and methods of the treatment
WO2012104793A1 (en) * 2011-02-02 2012-08-09 Indian Council Of Medical Research An antibacterial and antiviral compound
US20140243302A1 (en) 2011-06-27 2014-08-28 Merck Sharp & Dohme Corporation Bridged bicyclic compounds for the treatment of bacterial infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2272684A1 (en) * 1975-01-07 1975-12-26 Ito Shojiro Antibiotic-unsaturated acid compsns. - having a synergistic effect against gram positive and negative bacteria

Also Published As

Publication number Publication date
IL57798A (en) 1986-11-30
CZ280583B6 (cs) 1996-02-14
CZ513779A3 (en) 1995-10-18
AU4893279A (en) 1980-01-31
HU182973B (en) 1984-03-28
EP0007614B1 (en) 1983-01-26
IE51691B1 (en) 1987-02-18
PT69955A (en) 1979-08-01
PH16620A (en) 1983-11-28
NZ190993A (en) 1981-10-19
IE791388L (en) 1980-01-24
ES482774A1 (es) 1980-09-01
IL57798A0 (en) 1979-11-30
DD145059A5 (de) 1980-11-19
CA1136549A (en) 1982-11-30
GR69997B (es) 1982-07-23
DE2964609D1 (en) 1983-03-03
EP0007614A1 (en) 1980-02-06
FI792282A (fi) 1980-01-25
SK278357B6 (en) 1997-01-08
HK23286A (en) 1986-04-11
SK513779A3 (en) 1997-01-08
EG14367A (en) 1984-09-30
AU529315B2 (en) 1983-06-02
PT69955B (pt) 1981-06-11

Similar Documents

Publication Publication Date Title
DE2964609D1 (en) An antibacterial composition of thienamycin-type compound and a dipeptidase inhibitor
AU521129B2 (en) Determination of ammonia
ZA786950B (en) Method of preventing carcinogenesis
ZA792477B (en) Acaricidal and ovicidal heterocyclic compounds and compositions
ZA796465B (en) Compounds and compositions
JPS54112860A (en) Novel 22pyrrolidone compounds and their usage
JPS54140054A (en) Lighttweight compound article and its manufacture
NZ191839A (en) Aminoacyl- -halo-d-alanine compounds and antibacterial compositions
JPS55120585A (en) Novel pyrrole compound*its manufacture and enzyme inhibitor therefrom
JPS54151976A (en) Herbicidal compound and its application
GB2022601B (en) Sulphonato-organosilanol compounds and compositions
JPS54151973A (en) Novel compound*its manufacture and its compound
JPS5414974A (en) Novel radiationnphotosensitive compound and radiationnphotosensitive compositions containing same
IL57086A0 (en) Synergistic mixtures of antibiotic compounds
JPS55381A (en) Improved manufacture of 100deazaaminopterin and relative compounds
JPS54163825A (en) Phosphoesterase inhibitor
DE2965032D1 (en) Beta-lactam compounds
JPS54117473A (en) Manufacture of thiazole derivative and novel thiazole compound
JPS54122262A (en) Manufacture of betaasantalol*betaasantalene* dihydroobetaasantalol and related compounds
JPS53130699A (en) 44deoxyvlbba and b and 33oxidized derivative of related 11formyl compound
DE3173503D1 (en) Antibacterial composition of thienamycin type compound and a dipeptidase inhibitor
JPS54145624A (en) Novel compound and its manufacture
JPS5551023A (en) Use of thienamycin antibiotic together with dipeptidase inhibitor
JPS5576885A (en) Heterocyclic compound and its manufacture
JPS55153800A (en) Phosphonothioate compound and its manufacture